Application no. and date | 14722443.0 (espacenet) (Federated) (European Patent Register), 20140314 | Patent/reg. no. and date | DK/EP 2970224, 20170906 | Publication date | 20160120 | Priority no. and date | US 201361786086 P, 20130314, US 201361785608 P, 20130314, US 201361847780 P, 20130718, US 201361856847 P, 20130722, US 201361883843 P, 20130927, US 201361883798 P, 20130927, US 201461941798 P, 20140219, AR P014100970, 20140313 | EP pub. no. and date |
EP 2970224 20160120 | Effective date | | Applicant/owner | Onyx Therapeutics, Inc., One Amgen Center Drive
Thousand Oaks, CA 91320-1799, US | Applicant ref. no. | V542DKEP | Inventor | MCMINN, Dustin, 255 Kent Road
Pacifica, CA 94044, US, JOHNSON, Henry, 360 Hazel Avenue
San Bruno, CA 94066, US, BOWERS, Simeon, 3252 Bridsall Avenue
Oakland, CA 94619, US, MOEBIUS, David, C., 804 Balboa Lane
Foster City, CA 94404, US | Representative | JESPER LEVIN A/S, Jægersborg Alle 93, 2820 Gentofte, DK | Opponent | | IPC Class | A61K 31/336 (2006.01) , A61K 31/404 (2006.01) , A61P 29/00 (2006.01) , C07D 303/32 (2006.01) , C07D 405/12 (2006.01) , C07D 409/12 (2006.01) | Title | TRIPEPTIDEPOXYKETONPROTEASEHÆMMERE | Int. application no. | US2014026987 | Int. publication no. | WO2014152134 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|